To require the use of prescription drug monitoring programs and to facilitate information sharing among States.

United States115th CongressHR-1854House of Representatives
Updated: Apr 24, 2017

Summary

Prescription Drug Monitoring Act of 2017 This bill requires a state that receives grant funds under the prescription drug monitoring program (PDMP) or the controlled substance monitoring program to comply with specified requirements, including a requirement to share its PDMP data with other states. The Department of Justice (DOJ) or Department of Health and Human Services may withhold grant funds from a state that fails to comply. To facilitate data sharing among states, the bill directs DOJ to award a grant under the Comprehensive Opioid Abuse Grant Program to establish and maintain a data-sharing hub.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-778: A bill to require the use of prescription drug monitoring programs and to facilitate information sharing among States.

Introduced in Senate

  1. Introduced in House

  2. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    House of Representatives

All available records shown.